Keyphrases
Breast Cancer
59%
Shear Wave Elastography
45%
Core Needle Biopsy
37%
Ultrasound
32%
Invasive Breast Cancer
31%
Mammography
28%
Stiffness
26%
Mammogram Images
21%
Screen-detected
21%
Breast
21%
Tumor
21%
Neoadjuvant Chemotherapy
20%
Response to Neoadjuvant Chemotherapy
20%
Mammography Screening
18%
Ductal Carcinoma in Situ
18%
Magnetic Resonance Imaging
15%
Breast Imaging
15%
Ultrasound Features
14%
Breast Screening
13%
Biopsy Diagnosis
12%
Breast Cancer Survival
11%
Breast Carcinoma
11%
Skin Thickening
10%
Mammographic Features
10%
Breast Cancer Mortality
10%
Breast MRI
10%
Metastatic Disease
10%
Solid Breast Lesions
9%
Lesion Size
9%
Breast Cancer Patients
9%
Pathological Complete Response
9%
Pathological Response
9%
Malignancy
8%
Histological Grade
8%
Solid Breast Mass
8%
Breast Screening Programme
8%
Human Epidermal Growth Factor Receptor 2 (HER2)
8%
Axillary Lymph Node Metastasis
8%
European Society
8%
Shear Wave
8%
Digital Breast Tomosynthesis
8%
Greyscale
8%
Invasive Cancer
7%
Breast Lesions
7%
Residual Cancer Burden
7%
Women with Breast Cancer
7%
Tumor Subtype
7%
Prognostic Factors
7%
Excision
7%
Lobular Neoplasia
7%
Medicine and Dentistry
Breast Cancer
100%
Neoplasm
44%
Shear Wave Elastography
42%
Biopsy Technique
35%
Cancer
33%
Neoadjuvant Chemotherapy
31%
Mammography
31%
Malignant Neoplasm
22%
Magnetic Resonance Imaging
21%
Breast Lesion
17%
Intraductal Carcinoma
17%
Breast Screening
17%
Metastatic Carcinoma
17%
Core Needle Biopsy
14%
Randomized Controlled Trial
14%
Breast Tumor
13%
Cancer Mortality
13%
Breast Imaging
11%
Digital Breast Tomosynthesis
10%
Magnetic Resonance Imaging of Breast
10%
Cancer Specific Survival
10%
Breast Carcinoma
8%
Prognostic Factor
8%
Breast Imaging - Reporting And Data System
8%
Cancer Diagnosis
8%
Breast Ultrasound
7%
Tumor Invasion
7%
Overdiagnosis
7%
Diseases
6%
Diagnostic Accuracy
6%
Elastography
6%
Axillary Lymph Node
6%
Radiology
5%
Carcinoma
5%
Fibroadenoma
5%
Metastasis Free Survival
5%
Systematic Review
5%
Breast Cancer Screening
5%
False Positive Result
5%